# Contact Ascent Peptides — Editorial Digest

> Reach the Ascent Peptides editorial desk regarding citations, corrections, or research-related correspondence about our Growth Hormone Axis research peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a literature digest most wants to hear.

## Editorial correspondence

Ascent Peptides welcomes correspondence on the research record: a citation we have rendered inaccurately, a regulatory status that has changed, or a peer-reviewed study about CJC-1295, Sermorelin or Tesamorelin that should be added to the [references page](/references). Corrections that improve the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That structure lets us verify a proposed change against the source quickly.

**Editorial mailbox:** editors@ascentpeptides.com

## What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. Ascent Peptides is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or judge whether a particular research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Answer requests from athletes subject to anti-doping rules about using these compounds, given that all three are prohibited in sport.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

A literature digest tracing three GHRH analogs through the peer-reviewed record — mechanism, evidence, and caution, but never a dose or a product.